文献速递产科母胎医学生殖医学

肾脏疾病女性的受孕方式与围产结局:澳大利亚人群队列研究

Conception methods and perinatal outcomes among women with kidney disorders: an Australian population-based cohort study.
PubMed 文献 · Hum Reprod · 2026-10-10

该回顾性队列纳入2009–2017年澳大利亚新南威尔士州与首都领地的活产与死产,比较有/无肾脏疾病女性的受孕方式及围产结局。肾脏疾病女性中3.3%的出生经ART受孕、1.9%经IUI/OI受孕、94.8%为自然受孕;无论受孕方式如何,其剖宫产、早产、低出生体重和低Apgar评分风险均高于无肾脏疾病女性。

要点

  • 肾脏疾病女性多数为自然受孕,但仍有相当比例使用MAR,且年龄偏大。
  • 无论受孕方式,肾脏疾病女性剖宫产、早产、低出生体重及低Apgar评分风险均升高。
  • 建议对肾脏疾病女性从备孕起早期识别并提供多学科专科照护。

核心结论

  • 在肾脏疾病女性中,无论自然受孕还是MAR受孕,不良围产结局风险均持续高于无肾脏疾病女性。

研究设计与样本

  • 澳大利亚新南威尔士州与首都领地2009–2017年回顾性队列,基于州围产期记录链接,纳入全部活产与死产。
  • 共911 229名婴儿、898 084次妊娠、606 488名母亲;其中10 858名婴儿(1.2%)出生于7 634名有肾脏疾病的母亲。
  • 肾脏疾病母亲所生婴儿中563名(5.2%)为MAR受孕,对应470名母亲。

主要发现

  • 肾脏疾病女性所生婴儿中3.3%经ART受孕、1.9%经IUI/OI受孕、94.8%为自然受孕。
  • MAR受孕者年龄大于自然受孕者:肾脏疾病组MAR中位33岁(IQR 30–37)vs自然受孕29岁(24–33),sdiff=0.80;无肾脏疾病组MAR中位34岁(31–38)vs自然受孕31岁(27–35),sdiff=0.71。
  • 肾脏疾病中最常见为肾小管间质疾病(MAR 62.1% vs自然受孕72.7%)和尿路结石(MAR 36.8% vs自然受孕27.2%)。
  • MAR治疗中最常见为新鲜胚胎移植(肾脏疾病33.6% vs无肾脏疾病37.4%)、冻融胚胎移植(28.7% vs 29.5%)、任何OI/IUI(36.0% vs 31.8%)及单用枸橼酸氯米芬OI(27.0% vs 23.5%)。

关键数值与推荐

  • 调整母亲年龄、产次、相对社会经济劣势指数、多胎及既往糖尿病、高血压和心血管疾病后,肾脏疾病女性剖宫产风险升高(MAR:OR 1.49,95%CI 1.22–1.81;自然受孕:1.36,1.29–1.44)。
  • 早产风险升高(MAR:OR 2.09,95%CI 1.62–2.70;自然受孕:1.76,1.64–1.89)。
  • 低出生体重风险升高(MAR:OR 1.69,95%CI 1.27–2.27;自然受孕:1.54,1.41–1.67)。
  • 低Apgar评分风险升高(MAR:OR 1.37,95%CI 1.06–1.79;自然受孕:1.17,1.09–1.26)。

临床怎么用

  • 对肾脏疾病女性应在备孕及妊娠全程进行早期识别与多学科专科管理。
  • 应认识到即使自然受孕,肾脏疾病女性的不良围产结局风险仍升高,需加强监测。

局限性

  • 仅纳入获得出生的女性,未包括MAR后未妊娠或流产者,故无法评估MAR成功率。
  • 肾脏疾病与不良围产结局的关联不应解释为因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do conception methods and related pregnancy outcomes differ between women with and without kidney disease? SUMMARY ANSWER: In this cohort, 3.3% of births among women with kidney disorders were conceived using ART, 1.9% were conceived following IUI and ovulation induction (OI), and 94.8% were conceived spontaneously; however, women with kidney disorders consistently experienced higher risks of adverse pregnancy outcomes than those without, regardless of conception method. WHAT IS KNOWN ALREADY: Kidney disorders can impair fertility and pregnancy outcomes, but population‑level data on the use of medically assisted reproduction (MAR), including ART, IUI, and OI, in this group are limited. STUDY DESIGN, SIZE, DURATION: This retrospective cohort study included all live births and stillbirths in New South Wales (NSW) and the Australian Capital Territory (ACT), Australia, between 2009 and 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: We used linked state perinatal records to identify births. Kidney disorder diagnoses before delivery were identified using hospital dataset diagnostic coding. Conception mode was classified as (i) spontaneous conception, (ii) IUI/OI, or (iii) ART (including IVF or ICSI or other procedures [e.g. gamete intra-fallopian transfer, surrogacy]) using the Australia and New Zealand Assisted Reproduction Database and the national claims databases for medical services and pharmaceutical dispensing. MAIN RESULTS AND THE ROLE OF CHANCE: During the study period, 911 229 babies were born from 898 084 pregnancies among 606 488 mothers in NSW/ACT. Among these, 10 858 babies (1.2%) were born to 7634 mothers with kidney disorders. Of the babies born to mothers with kidney disorders, 563 babies (5.2%), born to 470 mothers, were MAR-conceived. Women who conceived via MAR were older than those who conceived spontaneously in both groups (kidney disorders: MAR median age 33 (IQR: 30-37) years vs spontaneous median age 29 (24-33), standardized difference (sdiff) = 0.80; non-kidney disorders: MAR median age 34 (31-38) years vs spontaneous median age 31 (27-35), sdiff = 0.71). The most common kidney disorders were renal tubulo-interstitial diseases (MAR: 62.1% vs spontaneous: 72.7%) and urolithiasis (MAR: 36.8% vs spontaneous: 27.2%). The proportion of births conceived using ART was 3.3% among births to women with kidney disorders. The most common MAR treatments were fresh embryo transfers (33.6% kidney disorders vs 37.4% non-kidney disorders), frozen embryo transfers (28.7% vs 29.5%), any OI/IUI (36.0% vs 31.8%), and OI using clomiphene citrate alone (27.0% vs 23.5%). After adjusting for maternal age, parity, Index of Relative Socio-economic Disadvantage, multiple births and pre-existing diabetes, hypertension, and cardiovascular disease, women with kidney disorders had higher odds of caesarean section (MAR: OR 1.49, 95% CI 1.22-1.81; spontaneous: 1.36, 1.29-1.44), preterm birth (MAR: 2.09, 1.62-2.70; spontaneous: 1.76, 1.64-1.89), low birthweight (MAR: 1.69, 1.27-2.27; spontaneous 1.54, 1.41-1.67), and low Apgar scores (MAR 1.37, 1.06-1.79; spontaneous 1.17, 1.09-1.26) than women without kidney disorders, regardless of conception method. LIMITATIONS, REASONS FOR CAUTION: As our study included only women who achieved a birth, it did not include those who underwent MAR but did not conceive or those who experienced miscarriage; therefore, MAR success rates could not be assessed. The association between kidney disorders and adverse pregnancy outcomes should not be interpreted as causal. WIDER IMPLICATIONS OF THE FINDINGS: Although most births among women with kidney disorders were spontaneously conceived, MAR was utilized by a substantial proportion of women with and without kidney disorders, particularly among older women. Women with kidney disorders experienced higher risks of adverse pregnancy outcomes regardless of conception method, emphasizing the importance of early identification and specialized multidisciplinary care throughout the reproductive journey. FUNDING: This study is funded by the Australian National Health and Medical Research Council (APP1127437). DISCLOSURES: The National Perinatal Epidemiology and Statistics Unit (NPESU) at University of New South Wales (UNSW) received funding from the Fertility Society of Australia and New Zealand (FSANZ) to prepare annual and benchmarking reports using data from the Australian and New Zealand Assisted Reproductive Technology Database (ANZARD). G.M.C is the Director of the NPESU and an employee of UNSW. W.L. is a deputy editor for Human Reproduction. The remaining authors have no relevant disclosures for this study. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Hewawasam E, Jesudason S, Sluiter A, et al. Conception methods and perinatal outcomes among women with kidney disorders: an Australian population-based cohort study. Hum Reprod. 2026. PMID: 42857894. doi:10.1093/humrep/deag161

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。